These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. Daroszewska A, Hocking LJ, McGuigan FE, Langdahl B, Stone MD, Cundy T, Nicholson GC, Fraser WD, Ralston SH. J Bone Miner Res; 2004 Sep 18; 19(9):1506-11. PubMed ID: 15312251 [Abstract] [Full Text] [Related]
6. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. Hosogane N, Miyamoto T. Clin Calcium; 2010 Oct 18; 20(10):1540-4. PubMed ID: 20890037 [Abstract] [Full Text] [Related]
12. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK. Whyte MP, Tau C, McAlister WH, Zhang X, Novack DV, Preliasco V, Santini-Araujo E, Mumm S. Bone; 2014 Nov 18; 68():153-61. PubMed ID: 25063546 [Abstract] [Full Text] [Related]
13. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. Lucas GJ, Daroszewska A, Ralston SH. J Bone Miner Res; 2006 Dec 18; 21 Suppl 2():P31-7. PubMed ID: 17229006 [Abstract] [Full Text] [Related]
14. Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype. Naot D, Wilson LC, Allgrove J, Adviento E, Piec I, Musson DS, Cundy T, Calder AD. Bone; 2020 Jan 18; 130():115098. PubMed ID: 31655221 [Abstract] [Full Text] [Related]
15. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders. Ralston SH. Best Pract Res Clin Rheumatol; 2008 Mar 18; 22(1):101-11. PubMed ID: 18328984 [Abstract] [Full Text] [Related]
16. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. Gottesman GS, Madson KL, McAlister WH, Nenninger A, Wenkert D, Mumm S, Whyte MP. Am J Med Genet A; 2016 Apr 18; 170A(4):978-85. PubMed ID: 26762549 [Abstract] [Full Text] [Related]
17. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). Polyzos SA, Singhellakis PN, Naot D, Adamidou F, Malandrinou FC, Anastasilakis AD, Polymerou V, Kita M. J Clin Endocrinol Metab; 2014 Mar 18; 99(3):703-7. PubMed ID: 24433001 [Abstract] [Full Text] [Related]
18. [Role of OPG in regulation of bone remodeling]. Nakamichi Y, Udagawa N. Clin Calcium; 2006 Sep 18; 16(9):1463-68. PubMed ID: 16951469 [Abstract] [Full Text] [Related]
19. Alport syndrome. Molecular genetic aspects. Hertz JM. Dan Med Bull; 2009 Aug 18; 56(3):105-52. PubMed ID: 19728970 [Abstract] [Full Text] [Related]
20. Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation. Prata AR, Saraiva J, Salgado M, Estanqueiro P. Joint Bone Spine; 2021 Dec 18; 88(6):105243. PubMed ID: 34166796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]